-- Winners of the Prix Galien UK and Prix Galien International Awards were recognized last night in a combined award ceremony honouring innovation that improves the human condition
LONDON, May 13, 2022 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, announced winners for the 2022 Prix Galien UK Awards last night at the Natural History Museum, London. Awards for "Best Biotechnology Product," "Best Pharmaceutical Product," "Best Medical Technology" and "Best Digital Health Solution" were awarded to industry leaders dedicated to innovation that improves the human condition. In conjunction with the Prix Galien UK Awards, The Galien Foundation also announced winners for the 2022 Prix Galien International Awards for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product" and "Best Vaccine."
"It was incredibly special to have a combined celebration of both the UK and International Prix Galien Awards at last night's ceremony," said Bruno Cohen, Chairman of The Galien Foundation. "The goal of our Prix Galien Awards is to bring together the dedicated members of our industry in one place, for a night of honouring their hard work. We were thrilled to see everyone together, in-person, for a beautiful evening recognizing innovation across the world."
The 2022 Prix Galien UK Award Winners
Best Biotechnology Product | Alnylam Pharmaceuticals | ONPATTRO |
Moderna | SPIKEVAX | |
Best Pharmaceutical | Novo Nordisk Ltd. | Rybelsus |
Best Medical Technology | Cyted Ltd
| Cytosponge |
Best Digital Health Solution | behold.ai | red dot V2 Clinical Analysis |
"It was remarkable to be in the company of many great innovators who have dedicated their lives to bringing better health to patients around the world through their groundbreaking work in research and development," said Professor Sir Mark Walport, Honorary Distinguished Professor of Medicine, Imperial College, and Prix Galien UK Committee Chair. "The Prix Galien Award Committees evaluated extraordinary companies and product candidates for this year's Prix Galien Awards, and we remain inspired by their commitment to advancing the quality of care provided for all."
The 2022 Prix Galien International Award Winners
Best Biotechnology Product | Novartis Pharmaceuticals | LUXTURNA (voretigene |
Best Pharmaceutical | Novartis Pharmaceuticals | Entresto (sacubitril/valsartan) |
Best Medical Technology | Abbott
| Abbott's MitraClip Transcatheter |
Best Digital Health Solution | Huma | Huma Therapeutic's Remote Patient |
Medtronic | Sistema MiniMed 780G | |
Best Vaccine | Pfizer Inc./ BioNTech | Comirnaty |
"After a pause due to the COVID-19 pandemic, it was particularly special being safely in-person, celebrating the 'best of the best' industry leaders at last night's ceremony," said Dr. Sue Desmond-Hellmann, Chair of the Prix Galien USA and Prix Galien International Award Committees and former CEO of the Bill & Melinda Gates Foundation. "The Prix Galien International Awards presents the opportunity to showcase dedication and innovation from around the world, and it was an honour to experience that under one roof."
Prix Galien UK Awards Committee 2022
Professor Sir Mark WALPORT
Honorary Distinguished Professor of Medicine, Imperial College
Committee Chair
Dr Jane ADAM
Chair, NICE technology appraisal committee and consultant, St. George's NHS Trust
Professor Bruce CAMPBELL
Consultant Vascular Surgeon, Exeter
Ms Tabitha GOLDSTAUB
Co-founder, CognitionX
Dame Parveen KUMAR, DBE
Emeritus Professor of Medicine and Education, Queen Mary University of London
Sir Robert LECHLER
Emeritus Senior Vice President (health), King's College London
Sir Munir PIRMOHAMED
David Weatherall Chair of Medicine, University of Liverpool, Liverpool
Dame June RAINE
Chief Executive, Medicines and Healthcare products Regulatory Agency
Professor Duncan RICHARDS
Professor of Clinical Therapeutics, University of Oxford
Professor Liam SMEETH
Director, London School of Hygiene and Tropical Medicine
Professor Rosalind SMYTH
Director and Professor of Child Health, UCL Great Ormond St Institute of Child Health
Professor David WEBB
Christison Chair of Therapeutics & Clinical Pharmacology, University of Edinburgh
Professor Moira WHYTE
Vice Principal and Head of the College of Medicine and Veterinary Medicine, Sir John Crofton Professor of Respiratory Medicine, University of Edinburgh
Professor Elizabeth WILLIAMSON
Professor of Biostatistics and Health Data Science, London school of Hygiene & Tropical Medicine
Prix Galien International Awards Committee
Pr. Susan DESMOND-HELLMANN,
M.D., M.Ph. Former Chief Executive Officer of the Bill & Melinda Gates Foundation, Seattle, WA
Committee Chair Prix Galien USA & International
Pr. Dr. J. (Koos) Burggraaf,
Professor of Translational Drugs Research at the Division of Pharmacology at the Leiden Academic Centre for Drug Research and CEO of the Centre for Human Drug Research (CHDR)
The Netherlands
Pr. Luigi Canonico,
Professor of Pharmacology, Università del Piemonte, Orientale Amedeo Avogadro
Italy
Pr. George P. Chrousos,
Professor of Pediatrics and Endocrinology Emeritus and former chairman of the Department of Pediatrics at the Athens University Medical School
Greece
Pr. Awa Marie Coll-Seck,
MD, PhD, Minister of State, Senegal and Chair of Prix Galien Africa
Africa
Pr. Erland Erdmann,
M.D., Professor of Cardiology, University of Cologne
Germany
Pr. Jean Gray,
Professor Emeritus Medical Education, Medicine and Pharmacology, Dalhousie University
Canada
Pr. Loic Guillevin,
Professor of Internal Medicine and Therapeutics & Founder, Former President
France
Pr. J.M. Parmentier,
Professor, Université Libre de Bruxelles
Belgium-Luxemburg
Pr. Christoph Renner,
M.D., Specialist, Hematology & Internal Medicine
Switzerland
Pr. Marlies Schijven,
M.D., MSc, PhD., Gastrointestinal Surgeon, AMC Amsterdam
Netherlands
Pr. Cezary Szyczylik,
M.D., Head, Department of Oncology, Central Clinical Hospital, Ministry of Interior and Administration
Poland
Pr. Sir Mark Walport,
Honorary Distinguished Professor of Medicine, Imperial College, Committee Chair, Prix Galien UK Awards Committee
United Kingdom
About the Galien Foundation
The Galien Foundation fosters, recognises and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.
The Foundation oversees and directs activities in the UK for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honour of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
For more information, visit www.galienfoundation.org.
Follow the Foundation on social media: https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/
Media Contact (UK):
Julian Tyndale-Biscoe
Finn Partners
Julian.Tyndale-biscoe@finnpartners.com
+44 20 3217 7060
Media Contact (Global):
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
646-213-7243
Logo - https://mma.prnewswire.com/media/564722/The_Galien_Foundation_Logo.jpg
